Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hospital, Pathology Lab Cost Burden Downplayed By GAO In TC Billing Review

This article was originally published in The Gray Sheet

Executive Summary

CMS' annual recalibration of relative payment weights under PPS eventually would offset costs incurred by hospitals if labs were no longer able to bill directly to Medicare for certain pathology services, GAO finds

You may also be interested in...



Medicare lab billing

HCFA delays until Jan. 1, 2001 its requirement that independent laboratories bill hospitals, rather than HCFA, for the technical component of outpatient pathology services. Originally intended to take effect Aug. 1, the requirement forces labs to bill multiple payers for one service. Delay follows lobbying effort by the American Hospital Association, the College of American Pathologists, and the National Rural Health Association, who informed the agency in a June 29 letter that "too many adjustments are being required of hospital billing and computer systems at this time to allow them to absorb this additional change"

Fujifilm Demonstrates Health Specialism With European HealthTech Spinout

From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics. 

Financing Quarterly Statistics, Q1 2024

During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019117

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel